2. Academic Validation
  3. CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma

CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma

  • Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:771-4.
A Beck 1,  A Sallmann,  P Wenk,  F Märki,  M A Bray
Affiliations

Affiliation

  • 1 Research Department, CIBA-GEIGY Ltd., Basle, Switzerland.
PMID: 2960189
Figures
Products